{"id":547925,"date":"2026-03-27T06:20:19","date_gmt":"2026-03-27T06:20:19","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/547925\/"},"modified":"2026-03-27T06:20:19","modified_gmt":"2026-03-27T06:20:19","slug":"is-ataibeckley-inc-atai-looking-to-sell-its-flagship-psychedelic-drug-candidate-bpl-003","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/547925\/","title":{"rendered":"Is AtaiBeckley Inc (ATAI) Looking to Sell Its Flagship Psychedelic Drug Candidate BPL-003?"},"content":{"rendered":"\n

AtaiBeckley Inc (NASDAQ:ATAI<\/a>) is among the best psychedelic stocks to buy in 2026<\/a>. On March 17, AtaiBeckley Inc (NASDAQ:ATAI) announced the publication in the Journal of Psychopharmacology of the Phase 2a study results for its flagship psychedelic drug candidate BPL-003. AtaiBeckley is developing BPL-003, which comes in the form of a nasal spray, as a treatment for treatment-resistant depression.<\/p>\n

\"Is Is AtaiBeckley Inc (ATAI) Looking to Sell Its Flagship Psychedelic Drug Candidate BPL-003? <\/p>\n

In that study, BPL-003 was evaluated in patients with moderate-to-severe treatment-resistant depression who were not on antidepressants. The study turned positive results on safety and efficacy.<\/p>\n

With that, BPL-003 is advancing to Phase 3 trials. AtaiBeckley announced on March 10 that it plans to launch two parallel Phase 3 studies of BPL-003 in Q2 2026. The Phase 3 trials announcement followed a meeting with the FDA, with the company saying that the regulator indicated support for the Phase 3 program and provided constructive feedback.<\/p>\n

On March 7, Bloomberg reported that AtaiBeckley was seeking a deal for BPL-003, which could be a sale or partnership. An outright sale of BPL-003 could fetch more than $2 billion for the company, while a partnership would involve sharing responsibilities and profit, according to the report.<\/p>\n

New York-headquartered AtaiBeckley Inc (NASDAQ:ATAI) a clinical-stage biopharmaceutical company focused on developing mental health treatments. The company has multiple drug candidates in the pipeline, including BPL-003, which is aimed at people with treatment-resistant depression.<\/p>\n

While we acknowledge the potential of ATAI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the\u00a0best short-term AI stock<\/a>.<\/p>\n

READ NEXT:\u00a033 Stocks That Should Double in 3 Years<\/a>\u00a0and\u00a015 Stocks That Will Make You Rich in 10 Years<\/a>.<\/p>\n

Disclosure: None. Follow Insider Monkey on Google News<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"AtaiBeckley Inc (NASDAQ:ATAI) is among the best psychedelic stocks to buy in 2026. On March 17, AtaiBeckley Inc…\n","protected":false},"author":2,"featured_media":547926,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58],"tags":[244233,244234,97,243,244235,84424,244236],"class_list":{"0":"post-547925","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-ataibeckley-inc","9":"tag-bpl-003","10":"tag-health","11":"tag-medication","12":"tag-study-results","13":"tag-treatment-resistant-depression","14":"tag-york-headquartered-ataibeckley-inc"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/547925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=547925"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/547925\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/547926"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=547925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=547925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=547925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}